VEBINOVE

Serial Number 86671106
606

Registration Progress

Application Filed
Jun 23, 2015
Under Examination
May 31, 2016
Approved for Publication
Apr 5, 2016
Published for Opposition
Apr 5, 2016
Registered

Trademark Image

VEBINOVE

Basic Information

Serial Number
86671106
Filing Date
June 23, 2015
Published for Opposition
April 5, 2016
Abandonment Date
July 1, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 1, 2019
Classes
005

Rights Holder

Pfizer Inc.

03
Address
235 East 42nd Street
New York, NY 10017

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Katrina Edge

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

38 events
Date Code Type Description Documents
Jul 1, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 1, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 23, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 22, 2018 EX5G S SOU EXTENSION 5 GRANTED Loading...
Oct 18, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 11, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 11, 2018 EXT5 S SOU EXTENSION 5 FILED Loading...
May 1, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 27, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 27, 2018 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 27, 2018 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 14, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 12, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 12, 2017 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 12, 2017 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 8, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 5, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 5, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 5, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 16, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 14, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 14, 2016 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 14, 2016 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 31, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 5, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 5, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 16, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 2, 2016 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 2, 2016 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 2, 2016 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 2, 2016 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 2, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 24, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 24, 2015 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 24, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 23, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 30, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 26, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The wording "VEBINOVE" has no meaning in a foreign language.

Classification

International Classes
005